• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建模 SARS-CoV-2 德尔塔变异株在部分接种人群中的传播。

Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.

机构信息

Programa de Doctorado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.

Facultad de Matemáticas, Universidad Autónoma de Yucatán, Anillo Periférico Norte, Tablaje Catastral 13615, Mérida 97119, Mexico.

出版信息

Viruses. 2022 Jan 16;14(1):158. doi: 10.3390/v14010158.

DOI:10.3390/v14010158
PMID:35062363
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8781299/
Abstract

In a population with ongoing vaccination, the trajectory of a pandemic is determined by how the virus spreads in unvaccinated and vaccinated individuals that exhibit distinct transmission dynamics based on different levels of natural and vaccine-induced immunity. We developed a mathematical model that considers both subpopulations and immunity parameters, including vaccination rates, vaccine effectiveness, and a gradual loss of protection. The model forecasted the spread of the SARS-CoV-2 delta variant in the US under varied transmission and vaccination rates. We further obtained the control reproduction number and conducted sensitivity analyses to determine how each parameter may affect virus transmission. Although our model has several limitations, the number of infected individuals was shown to be a magnitude greater (~10×) in the unvaccinated subpopulation compared to the vaccinated subpopulation. Our results show that a combination of strengthening vaccine-induced immunity and preventative behavioral measures like face mask-wearing and contact tracing will likely be required to deaccelerate the spread of infectious SARS-CoV-2 variants.

摘要

在持续进行疫苗接种的人群中,大流行的轨迹取决于病毒在未接种疫苗和接种疫苗的个体中的传播方式,这些个体表现出不同的传播动态,这取决于不同水平的自然和疫苗诱导的免疫力。我们开发了一个数学模型,该模型同时考虑了亚人群和免疫参数,包括疫苗接种率、疫苗有效性以及保护作用的逐渐丧失。该模型预测了 SARS-CoV-2 德尔塔变体在美国不同传播和疫苗接种率下的传播情况。我们进一步获得了控制繁殖数,并进行了敏感性分析,以确定每个参数如何影响病毒传播。尽管我们的模型存在一些局限性,但与接种疫苗的亚人群相比,未接种疫苗的亚人群中感染人数要高出一个数量级 (~10×)。我们的结果表明,可能需要加强疫苗诱导的免疫力以及戴口罩和接触者追踪等预防性行为措施的结合,以减缓传染性 SARS-CoV-2 变体的传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/78952382d278/viruses-14-00158-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/f43acfa698cb/viruses-14-00158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/47979e652c16/viruses-14-00158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/277e23cdb91e/viruses-14-00158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/aa5e1bc4389c/viruses-14-00158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/f76747acc7b7/viruses-14-00158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/71409aa53dcd/viruses-14-00158-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/78952382d278/viruses-14-00158-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/f43acfa698cb/viruses-14-00158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/47979e652c16/viruses-14-00158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/277e23cdb91e/viruses-14-00158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/aa5e1bc4389c/viruses-14-00158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/f76747acc7b7/viruses-14-00158-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/71409aa53dcd/viruses-14-00158-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bee/8781299/78952382d278/viruses-14-00158-g007.jpg

相似文献

1
Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.建模 SARS-CoV-2 德尔塔变异株在部分接种人群中的传播。
Viruses. 2022 Jan 16;14(1):158. doi: 10.3390/v14010158.
2
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州,2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
3
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.Ad26.COV2.S腺病毒载体疫苗预防新型冠状病毒肺炎的有效性分析
JAMA Netw Open. 2021 Nov 1;4(11):e2132540. doi: 10.1001/jamanetworkopen.2021.32540.
4
Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority.免疫逃避、衰减和增强对疫苗接种多数人群与未接种少数人群混合动态的影响。
PLoS One. 2024 Apr 4;19(4):e0297093. doi: 10.1371/journal.pone.0297093. eCollection 2024.
5
Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.异源疫苗接种干预措施以降低大流行的发病率和死亡率:模拟美国 2020 年冬季 COVID-19 浪潮。
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3). doi: 10.1073/pnas.2025448119.
6
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
7
Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.作为奥克兰新新西兰的德尔塔和奥密克戎变体的随机模型调查,接种疫苗状态对感染或感染 COVID-19 的可能性的影响。
N Z Med J. 2022 Apr 1;135:89-100.
8
Will vaccine-derived protective immunity curtail COVID-19 variants in the US?疫苗衍生的保护性免疫能否在美国遏制新冠病毒变种?
Infect Dis Model. 2021;6:1110-1134. doi: 10.1016/j.idm.2021.08.008. Epub 2021 Sep 9.
9
Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment.解析2019冠状病毒奥密克戎变异株和德尔塔变异株在接种疫苗、佩戴口罩及抗病毒治疗情况下的动态变化。
Appl Math Model. 2023 Feb;114:447-465. doi: 10.1016/j.apm.2022.09.017. Epub 2022 Sep 30.
10
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.接种疫苗和未接种疫苗个体中的 SARS-CoV-2 传播和传染性脱落动力学。
JAMA Netw Open. 2022 May 2;5(5):e2213606. doi: 10.1001/jamanetworkopen.2022.13606.

引用本文的文献

1
A systematic literature review on public health and healthcare resources for pandemic preparedness planning.系统文献回顾:大流行准备规划中的公共卫生和医疗资源
BMC Public Health. 2024 Nov 11;24(1):3114. doi: 10.1186/s12889-024-20629-z.
2
Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects.接种疫苗影响下的新冠病毒奥密克戎毒株浪潮的数学建模
Computation (Basel). 2023 Feb;11(2). doi: 10.3390/computation11020036. Epub 2023 Feb 15.
3
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.

本文引用的文献

1
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.SARS-CoV-2 Lambda 变体表现出增强的感染力和免疫抗性。
Cell Rep. 2022 Jan 11;38(2):110218. doi: 10.1016/j.celrep.2021.110218. Epub 2021 Dec 18.
2
Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations.基于模型的对部分接种疫苗的K-12学校人群中新冠病毒德尔塔变异株传播动态的评估。
Lancet Reg Health Am. 2022 Jan;5:100133. doi: 10.1016/j.lana.2021.100133. Epub 2021 Nov 25.
3
Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study.
预测 SARS-CoV-2 导致的健康结果的模型,包括疫苗接种的效果:系统评价。
Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1.
4
An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants.奥密克戎 XBB.1.5 等变异株的流行病学特征、免疫逃逸及治疗进展的更新综述。
Front Cell Infect Microbiol. 2023 Dec 14;13:1297078. doi: 10.3389/fcimb.2023.1297078. eCollection 2023.
5
Global stability and optimal control for a COVID-19 model with vaccination and isolation delays.具有疫苗接种和隔离延迟的COVID-19模型的全局稳定性和最优控制
Results Phys. 2022 Nov;42:106011. doi: 10.1016/j.rinp.2022.106011. Epub 2022 Sep 24.
与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株(B.1.617.2)相关的2019冠状病毒病病例的家庭传播:全国病例对照研究
Lancet Reg Health Eur. 2022 Jan;12:100252. doi: 10.1016/j.lanepe.2021.100252. Epub 2021 Oct 28.
4
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.Delta 变异株导致的指数级增长、高 SARS-CoV-2 流行率和疫苗效力。
Science. 2021 Dec 17;374(6574):eabl9551. doi: 10.1126/science.abl9551.
5
Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission.疫苗预防 SARS-CoV-2 传播的数学建模。
Viruses. 2021 Sep 24;13(10):1921. doi: 10.3390/v13101921.
6
Epidemiological and economic impact of COVID-19 in the US.新冠疫情对美国的流行病学和经济影响。
Sci Rep. 2021 Oct 14;11(1):20451. doi: 10.1038/s41598-021-99712-z.
7
Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes.亚太五国在 COVID-19 大流行第一波期间的经验:缓解策略和流行病学结果。
Travel Med Infect Dis. 2021 Nov-Dec;44:102171. doi: 10.1016/j.tmaid.2021.102171. Epub 2021 Oct 12.
8
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance.德尔塔变异株(B.1.617.2)亚谱系未表现出中和抗性增加。
Cell Mol Immunol. 2021 Nov;18(11):2557-2559. doi: 10.1038/s41423-021-00772-y. Epub 2021 Oct 11.
9
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination.B.1.617.2 以更高的效率进入并融合肺部细胞,并逃避由感染和接种疫苗引起的抗体。
Cell Rep. 2021 Oct 12;37(2):109825. doi: 10.1016/j.celrep.2021.109825. Epub 2021 Sep 28.
10
Will vaccine-derived protective immunity curtail COVID-19 variants in the US?疫苗衍生的保护性免疫能否在美国遏制新冠病毒变种?
Infect Dis Model. 2021;6:1110-1134. doi: 10.1016/j.idm.2021.08.008. Epub 2021 Sep 9.